This site is intended for healthcare professionals

Sign in
Go to /sign-in page

You can view 5 more pages before signing in

Epidemiology

Last reviewed dd mmm yyyy. Last edited dd mmm yyyy

Authoring team

Haematuria is a common clinical finding in the primary care with a higher incidence in patients over 40 years old (1).

  • prevalence of asymptomatic microscopic haematuria varies between 0.19 and 21%
    • in the UK, prevalence of asymptomatic microscopic haematuria in adult male population is around 2.5%.
    • this figure is thought to increase with age - up to 22% of males over 60 years of age having asymptomatic microscopic haematuria (2)
  • 1% to 3% of patients with non-visible haematuria have urinary tract cancer (3) and macroscopic haematuria has been found to be the presenting symptom in in >66% of patients with urological malignancy (4)

Reference:

  1. Benton T et al. Assessment of non-visible haematuria, BMJ Best Practice, 2021
  2. Rodgers M et al. Diagnostic tests and algorithms used in the investigation of haematuria: systematic reviews and economic evaluation; Health Technology Assessment 2006;10(18)
  3. Samson P, Waingankar N, Shah P, et al. Predictors of genitourinary malignancy in patients with asymptomatic microscopic hematuria. Urol Oncol. 2018 Jan;36(1):10.e1-10.e6.
  4. Edwards TJ, Dickinson AJ, Natale S, et al. A prospective analysis of the diagnostic yield resulting from 4020 patients at a protocol-driven haematuria clinic. BJU Int. 2006 Feb;97(2):301-5

Create an account to add page annotations

Create a free account

Annotations allow you to add information to this page that would be handy to have on hand during a consultation. E.g. a website or number. This information will always show when you visit this page.

The content herein is provided for informational purposes and does not replace the need to apply professional clinical judgement when diagnosing or treating any medical condition. A licensed medical practitioner should be consulted for diagnosis and treatment of any and all medical conditions.

Connect

Copyright 2024 Oxbridge Solutions Limited, a subsidiary of OmniaMed Communications Limited. All rights reserved. Any distribution or duplication of the information contained herein is strictly prohibited. Oxbridge Solutions receives funding from advertising but maintains editorial independence.